Department of Surgery, Montefiore Medical Center, Bronx, NY, USA.
Transpl Int. 2013 Oct;26(10):963-72. doi: 10.1111/tri.12142. Epub 2013 Jul 3.
Outcomes of old-donor simultaneous pancreas-kidney transplantation (SPKT) have not been thoroughly studied. Scientific Registry of Transplant Recipients data reported for SPKT candidates receiving dialysis wait-listed between 1993 and 2008 (n = 7937) were analyzed for outcomes among those who remained listed (n = 3301) and of SPKT recipients (n = 4636) using multivariable time-dependent regression models. Recipients were stratified by donor/recipient age (cutoff 40 years) into: young-to-young (n = 2099), young-to-old (n = 1873), old-to-young (n = 293), and old-to-old (n = 371). The overall mortality was 12%, 14%, 20%, and 24%, respectively, for those transplanted, and 50% for those remaining on the waiting list. On multivariable analysis, old-donor SPKT was associated with significantly higher overall risks of patient death, death-censored pancreas, and kidney graft failure in both young (73%, 53%, and 63% increased risk, respectively) and old (91%, 124%, and 85% increased risk, respectively) recipients. The adjusted relative mortality risk was similar for recipients of old-donor SPKT compared with wait-listed patients including those who subsequently received young-donor transplants (aHR 0.95; 95% CI 0.78, 1.12) except for candidates in OPOs with waiting times ≥604 days (aHR 0.65, 95% CI 0.45-0.94). Old-donor SPKT results in significantly worse graft survival and patient mortality without any waiting-time benefit as compared to young-donor SPKT, except for candidates with expected long waiting times.
老年供者胰肾联合移植(SPKT)的结果尚未得到充分研究。分析了 1993 年至 2008 年期间接受透析等待名单的 SPKT 候选者的 Scientific Registry of Transplant Recipients 数据(n=7937),这些候选者中仍在名单上的(n=3301)和 SPKT 受者(n=4636)的结果使用多变量时间依赖回归模型进行分析。根据供体/受体年龄(截点 40 岁)将受者分为:年轻对年轻(n=2099)、年轻对年老(n=1873)、年老对年轻(n=293)和年老对年老(n=371)。移植患者的总体死亡率分别为 12%、14%、20%和 24%,而在等待名单上的患者为 50%。多变量分析显示,老年供体 SPKT 与年轻(分别为 73%、53%和 63%的风险增加)和老年(分别为 91%、124%和 85%的风险增加)受者的总体死亡、死亡相关胰腺和肾脏移植物失败的风险显著增加相关。与等待名单上的患者相比,包括随后接受年轻供体移植的患者(aHR 0.95;95%CI 0.78,1.12),老年供体 SPKT 受者的调整后的相对死亡率风险相似,除了在 OPO 中等待时间≥604 天的候选者(aHR 0.65,95%CI 0.45-0.94)。与年轻供体 SPKT 相比,老年供体 SPKT 导致移植物存活率和患者死亡率显著恶化,而没有任何等待时间的获益,除了预计等待时间较长的候选者。